Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors

Journal of Neuro-Oncology

Volumn 103, Issue 2, 2011, Pages 175-185

  Kawabata, Shinji ^d   Yang, Weilian ^a   Barth, Rolf F ^a   Wu, Gong ^a   Huo, Tianyao ^a   Binns, Peter J ^b,e   Riley, Kent J ^b,f   Ongayi, Owendi ^c   Gottumukkala, Vijay ^c   Vicente, M Graça H ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d OSAKA MEDICAL COLLEGE   (Japan)

^e MOUNT AUBURN HOSPITAL   (United States)

^f RADIATION MONITORING DEVICES INC   (United States)

Author keywords

Boron neutron capture therapy; Carboranylporphyrins; Convection enhanced delivery; F98 rat glioma

Indexed keywords

4 BORONOPHENYLALANINE; BORON; DI[3,5 (NIDO CARBORANYLMETHYL)PHENYL]PORPHYRIN; PORPHYRIN DERIVATIVE; TETRA(4 NIDO CARBORANYLPHENYL)PORPHYRIN; TETRA(4 NIDO CARBORANYLPHENYL)TETRA BENZOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RETENTION; DRUG TRANSPORT; DRUG TUMOR LEVEL; FEMALE; GLIOMA; HISTOPATHOLOGY; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; OSMOTIC PUMP; RADIATION DOSE; RAT; SINGLE DRUG DOSE; SURVIVAL TIME; TUMOR MODEL;

ANIMALS; BOROHYDRIDES; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CONVECTION; FEMALE; GLIOMA; MICE; MICE, INBRED C57BL; PORPHYRINS; RATS; TISSUE DISTRIBUTION;

EID: 79959850433     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0376-5     Document Type: Article

References (54)

1. Vicente MGH (2006) Boron in medicinal chemistry. Anti-cancer Agents Med Chem 6:73
2. Barth RF, Coderre JA, Vicente MGH, Blue TE (2005) Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11:3987-4002
3. Sköld K, H-Stenstam B, Diaz AZ et al (2010) Boron neutron capture therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f. Acta Neurol Scand 122:58-62
4. Sköld K, Gorlia T, Pellettieri L et al (2010) Boron neutron capture therapy for newly diagnosed glioblatoma multiforme: an assessment of clinical potential. Brit Radio 83:596-603
5. Miyatake S-I, Kawabata S, Yokoyama K et al (2009) Survival benefit of boron neutron capture therapy for recurrent malignant gliomas. J Neurooncol 91:199-206
6. Kawabata S, Miyatake S-I, Kuroiwa T et al (2009) Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res 50:51-60
7. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concimitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase UUU study: 5-year analysis of the ORTC-NCIC trial. Lancet Oncol 10:459-466
8. Altieri S, Bortolussi S, Barth RF, Roveda L, Zonta A (2009) Thirteenth international congress on neutron capture therapy. Appl Radiat Isot 67:S1-378
9. Fairchild RG, Kahl SB, Laster BH et al (1990) In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res 50:4860-4865
10. Hill JS, Kahl SB, Kaye AH et al (1992) Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci USA 89:1785-1789
11. Ceberg CP, Brun A, Kahl SB et al (1995) A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. J Neurosurg 83:86-92
12. Koo MS, Ozawa T, Santos RA et al (2007) Synthesis and comparative toxicology of a series of polyhedral borane anionsubstituted tetraphenyl porphyrins. J Med Chem 50:820-827 (Pubitemid 46332993)
13. Miura M, Joel DD, Smilowitz HM et al (2001) Biodistribution of copper carboranyltetraphenylporphyrins in rodents bearing an isogeneic or human neoplasm. J Neurooncol 52:111-117 (Pubitemid 32691173)
14. Miura M, Micca PL, Fisher CD et al (1998) Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy. Br J Radiol 71:773-781 (Pubitemid 28342464)
15. Miura M, Morris GM, Micca PL et al (2001) Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin. Radiat Res 155:603-610 (Pubitemid 32260258)
16. Tibbitts J, Fike JR, Lamborn KR et al (1999) Toxicology of a boronated porphyrin in dogs. Photochem Photobiol 69:587-594 (Pubitemid 129555481)
17. Tibbitts J, Sambol NC, Fike JR et al (2000) Plasma pharmacokinetics and tissue biodistribution of boron following administration of a boronated porphyrin in dogs. J Pharm Sci 89:469-477
18. Tsurubuchi T, Yamamoto T, Nakai K et al (2009) Intracellular uptake of a new boronated porphyrin EC032. Appl Radiat Isot 67:94-96
19. Viaggi M, Dagrosa MA, Longhino J et al (2004) Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP. Appl Radiat Isot 61:905-909 (Pubitemid 39092638)
20. Wu H, Micca PL, Makar MS, Miura M (2006) Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice. Bioorg Med Chem 14:5083-5092 (Pubitemid 43903273)
21. Renner MW, Miura M, Easson MW, Vicente MGH (2006) Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy. Anticancer Agents Med Chem 6:145-157 (Pubitemid 43796649)
22. Vicente MGH, Sibrian-Vazquez M (2010) Synthesis of boronated porphyrins and their application in BNCT. In: Kadish KM, Smith KM, Guilard R (eds) The handbook of porphyrin science, vol 4, chapter 18. World Scientific Publishers, Singapore, pp 191-248
23. Fabris C, Vicente MGH, Hao E et al (2007) Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl) porphyrin (H2TCP). J Photochem Photobiol B 89:131-138
24. Soncin M, Friso E, Jori G et al (2008) Tumor-localizing and radiosensitising properties of meso-tetra(4-nido-carboranylphenyl) porphyrin (H2TCP). J Porphyr Phthalcocya 12:866-873
25. Vicente MGH, Nurco DJ, Shetty SJ et al (2002) Synthesis, dark toxicity and induction of in vitro DNA photodamage by a tetra(4-nido-carboranylphenyl) porphyrin. J Photochem Photobiol B 68:123-132
26. Vicente MGH, Shetty S, Wickramasinghe A, Smith KM (2000) Syntheses of carbon-carbon linked carboranylated porphyrins for application in boron neutron capture therapy. Tetrahedron Lett 41:7626-7627
27. Vicente MGH, Wickramasinghe A, Nurco DJ et al (2003) Synthesis, toxicity and biodistribution of two 5, 15-di[3, 5-(nidocarboranylmethyl) phenyl]porphyrins in EMT-6 tumor bearing mice. Bioorg Med Chem 11:3101-3108 (Pubitemid 36773569)
28. Gottumukkala V, Ongayi O, Baker DG et al (2006) Synthesis, cellular uptake and animal toxicity of a tetra(carboranylphenyl)-tetrabenzoporphyrin. Bioorg Med Chem 14:1871-1879 (Pubitemid 43199519)
29. Ongayi O, Gottumukkala V, Fronczek FR, Vicente MG (2005) Synthesis and characterization of a carboranyl-tetrabenzoporphyrin. Bioorg Med Chem Lett 15:1665-1668 (Pubitemid 40312549)
30. Ozawa T, Afzal J, Lamborn KR et al (2005) Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model. Int J Radiat Oncol Biol Phys 63:247-252 (Pubitemid 41583565)
31. Ozawa T, Santos RA, Lamborn KR et al (2004) In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts. Mol Pharm 1:368-374
32. Yang W, Barth RF, Adams DM et al (2002) Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Res 62:6552-6558 (Pubitemid 35364121)
33. Morrison PF, Chen MY, Chadwick RS et al (1999) Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol 277:1218-1229
34. Mardor Y, Rahav O, Zauberman Y et al (2005) Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res 65:6858-6863 (Pubitemid 41065083)
35. Ferguson S, Lesniak MS (2007) Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors. Curr Drug Deliv 4:169-180 (Pubitemid 46557493)
36. Sampson JH, Akabani G, Archer GE et al (2008) Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol 10:320-329
37. Kawabata S, Barth RF, Yang W, et al (2006) Evaluation of carboranylporphyrins as boron delivery agents for neutron capture therapy. In: Proceedings for the 12th international congress on neutron capture therapy for cancer. Takamatsu, Japan, pp 123-126
38. Bobadova-Parvanova P, Oku Y, Wickramasinghe A, Hall RW, Vicente MGH (2004) Ab initio and 1H-NMR study of the Zn(II) complexes of a nido- and a close-carboranylporphyrin. J Porphyr Phthalcocya 8:996-1006
39. Newcomb EW, Zugzog D (2009) The murine GL261 glioma experimental mode to assess novel brain tumor treatments, Chap. 12. CNS Cancer. Human press, New York, pp 227-241
40. Barth RF, Adams DM, Soloway AH et al (1991) Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. Anal Chem 63:890-893
41. Ko L, Koestner A, Wechsler W (1980) Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol 51:23-31 (Pubitemid 10080528)
42. Barth RF, Kaur B (2009) Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 94:299-312
43. Barth RF, Yang W, Rotaru JH et al (2000) Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Int J Radiat Oncol Biol Phys 47:209-218
44. Rogus RD, Harling OK, Yanch JC (1994) Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR-II research reactor. Med Phys 21:1611-1625 (Pubitemid 24328891)
45. Barth RF, Wu G, Yang W et al (2004) Neutron capture therapy of epidermal growth factor (?) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. Appl Radiat Isot 61:899-903 (Pubitemid 39092637)
46. Madsen RW, Moeschberger ML (1986) Statistical concepts. Prentice-Hall, Englewood Cliffs, NJ
47. Klein JP, Moeschberger ML (2003) Survival analysis techniques for censored and truncated data, 2nd edn. Springer, New York
48. Jori G, Soncin M, Friso E et al (2009)Anovel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies. Appl Radiat Isot 67:321-324
49. Coderre JA, Glass JD, Fairchild RG et al (1987) Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. Cancer Res 47:6377-6383 (Pubitemid 18011092)
50. Shibata Y, Matsumura A, Yoshida F et al (1998) Cell cycle dependency of porphyrin uptake in a glioma cell line. Cancer Lett 129:77-85 (Pubitemid 28375241)
51. Chandra S, Tjarks W, Lorey DR, Barth RF (2008) Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS). J Microsc 229:92-103
52. Smith DR, Chandra S, Coderre JA, Barth RF (1997) Quantitative ion microscopy imaging of boron-10 in rat brain tumor models for BNCT. In: Larsson B, Crawford J, Weinrich R et al (eds) Advances in neutron capture therapy, vol II, chemistry and biology. Elsevier Science B.V., Amsterdam, pp 308-314
53. Smith DR, Chandra S, Coderre JA, Morrison GH (1996) Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy. Cancer Res 56:4302-4306 (Pubitemid 26330425)
54. Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J et al (2004) Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors. Cancer Res 64:6287-6295